Vitamin D Metabolism and Activation

Vitamin D is a secosteroid prohormone that must be metabolized in two sequential hydroxylation steps before it can act as a calcium-regulating hormone. Cholecalciferol (vitamin D3) is produced in skin from 7-dehydrocholesterol under ultraviolet light or obtained from the diet; it is then hydroxylated in the liver to 25-hydroxyvitamin D and finally in the kidney to the hormonally active 1,25-dihydroxyvitamin D, known as calcitriol.

Definition

Vitamin D metabolism is the two-step activation of the secosteroid prohormone vitamin D — hepatic conversion to 25-hydroxyvitamin D followed by renal 1-alpha-hydroxylation to the active hormone 1,25-dihydroxyvitamin D (calcitriol).

Scope

This topic covers the synthesis and activation pathway of vitamin D: cutaneous production, hepatic 25-hydroxylation, renal 1-alpha-hydroxylation to calcitriol, the regulation of the activating and inactivating enzymes by PTH, phosphate, FGF23, and calcitriol itself, and the rationale for measuring 25-hydroxyvitamin D as the indicator of vitamin D status. The mechanisms of calcitriol action on target organs are treated in a companion topic. This is a reference-educational account of normal physiology.

Key concepts

• 7-dehydrocholesterol and cutaneous synthesis
• Cholecalciferol (vitamin D3)
• Hepatic 25-hydroxylation
• 25-hydroxyvitamin D (calcidiol)
• Renal 1-alpha-hydroxylase (CYP27B1)
• 1,25-dihydroxyvitamin D (calcitriol)
• 24-hydroxylase (CYP24A1) and inactivation
• Regulation by PTH, phosphate, and FGF23

Mechanisms

Ultraviolet B radiation converts cutaneous 7-dehydrocholesterol to previtamin D3, which isomerizes to cholecalciferol; dietary vitamin D2 and D3 contribute additionally. In the liver, 25-hydroxylase produces 25-hydroxyvitamin D, the abundant circulating form and the standard marker of vitamin D status. The rate-limiting activation step occurs in the proximal renal tubule, where 1-alpha-hydroxylase (CYP27B1) generates the active hormone calcitriol. This renal step is the principal point of control: PTH and hypophosphatemia stimulate 1-alpha-hydroxylase, whereas FGF23 and calcitriol itself suppress it and induce the catabolic 24-hydroxylase (CYP24A1) that inactivates both 25-hydroxyvitamin D and calcitriol. This regulated activation links vitamin D status to the body's calcium and phosphate needs.

Clinical relevance

The metabolic pathway explains why 25-hydroxyvitamin D, rather than the active calcitriol, is used as the indicator of vitamin D status, and why kidney and liver function influence vitamin D activation. This entry describes normal physiology and is not a basis for diagnostic thresholds, supplementation, or treatment decisions.

History

The recognition that vitamin D is not active as ingested but must undergo successive hepatic and renal hydroxylations to a hormonal form was a major mid-to-late twentieth-century advance, reframing vitamin D as a prohormone within an endocrine system. Subsequent work characterized the activating and inactivating cytochrome P450 enzymes and the hormonal signals that regulate them, integrating vitamin D metabolism with PTH, phosphate, and FGF23 control.

Key figures

• Michael F. Holick
• Daniel D. Bikle
• Sylvia Christakos

Seminal works

• christakos-2016
• bikle-2014
• holick-2007

Frequently asked questions

Why does vitamin D need to be activated?

Ingested or skin-derived vitamin D is a prohormone; it becomes biologically active only after hepatic 25-hydroxylation and then renal 1-alpha-hydroxylation to calcitriol, the hormonal form.

Which form indicates vitamin D status?

25-hydroxyvitamin D is the abundant circulating metabolite and is used as the indicator of vitamin D status, whereas calcitriol is the short-lived active hormone.